Re-Export of Insulin Not in Dosage Forms
This key economic indicator for the Insulin sector has been recently updated.
- United States decreased by 22.6% of Re-Export of Insulin Not in Dosage Forms in 2019, compared to the previous year.
- Since 2014 United States Re-Export of Insulin Not in Dosage Forms jumped by 218.3% year on year at $4,155,438.
- In 2016 Jordan was ranked number 2 in Re-Export of Insulin Not in Dosage Forms totalising $14,085, from 3 in 2015.
Top Countries in Re-Export of Insulin Not in Dosage Forms
# | 4 Countries | US Dollars | Last | YoY | 5‑years CAGR | |
---|---|---|---|---|---|---|
1 |
#1
United States
|
4,155,438.00 | 2019 | -22.6 % | +218.3 % | View data |
2 |
#2
Jordan
|
14,085.00 | 2016 | NA | NA | View data |
3 |
#3
United Arab Emirates
|
544.59 | 2017 | -100.0 % | NA | View data |
4 |
#4
New Zealand
|
30.87 | 2015 | NA | NA | View data |
Source: United Nations Statistical Office